EU Report Shows Drop In Pay-For-Delay Deals
The number of pay-for-delay patent settlements and other agreements in the pharmaceutical industry that may run afoul of European competition law has dropped significantly over the past year and a half,...To view the full article, register now.
Already a subscriber? Click here to view full article